Professional Documents
Culture Documents
Dietary Management of GI Diseases: Jinky Harvey and Mah Asombang
Dietary Management of GI Diseases: Jinky Harvey and Mah Asombang
Dietary Management of GI Diseases: Jinky Harvey and Mah Asombang
Diseases
Atonic Constipation
Spastic Constipation
Atonic constipation
• also known as “lazy colon”
• a lack of normal muscle tone or strength in
the colon.
Who is affected?
• Elderly people or individuals who lack
physical activity.
• Obese individuals.
• Individuals recovering from a surgical
operation.
• During pregnancy or following childbirth.
• Individuals with a diet low in fiber and high
in fats
Most Important causes
• Inadequate diet
• Irregular meals
• Insufficient liquids and fibers
• Failure to establish a regular time for
defecation
Dietary Management
• High-fiber diet
• Regularity of habit through bowel training
program
• Eating regular meals
• Adequate fluids
• exercise
Dietary Management
Spastic constipation
• Also known as irritable colon syndrome.
• it is secondary to the overstimulationof the
intestinal nerve endings resulting in the
irregular contractions of the bowel.
Manifestations
• Uncoordinated • Heartburn
sigmoidal mobility • Flatulence
• Loss of rectal • Headache
sensibility • Palpitation
• Abdominal pain
• nervousness
• Belching
• Heartburn
Management
• A low fiber diet in order to avoid irritation of the
mucous membrane of the intestinal tract.
• Diet should consist of non-irritating foods, such
as; milk, eggs, refined bread and cereals, butter,
oil, finely ground meat, fish, poultry .
• Vitamin supplements are also recommended
during the period of a long restricted diet.
GASTRITIS
• A term used to describe a group of
condition with one thing in common:
inflammation of the stomach lining
• Results from infection w/same bacterium
that causes most stomach ulcers
• Other factors include traumatic injury &
regular use of certain pain relievers,
drinking too much alcohol can contribute to
gastritis
Classification
Acute gastritis: is an inflammation of the
gastric mucosa, occurs suddenly and
sometimes violent in onset.
Chronic gastritis: slowly develop over time
and it causes dull pain, feeling of fullness
and loss of appetite.
• Normal
• Increased Attack
Hyperacidity
• Weak defense
Helicobacter pylori
Stress, drugs, smoking
Signs and Symptoms
• Gnawing or burning pain in upper abdomen
• Loss of appetite
• Bloating
• Belching
• Nausea
• Vomiting
• Feeling of fullness after eating a meal
• Weight loss
Acute Gastritis
Acute mucosal inflammatory process of a
transient nature
Attacks follow after dietary indiscretions:
• Overeating
• Eating too quickly
• Eating while tired or stressed
• Specific food
Other factors:
• Spoiled foods containing staphylococci
• Drugs (salicylates, ammonium chloride)
Management
Dietary Management
• Initial Treatment
• Remove offending substance ASAP by emptying
the stomach: induced vomiting and lavage or both
• NPO for 24-48hrs
• Initiate IV fluids
• After fasting period:
• Low fiber liquid diet can be given as tolerated
• Milk, toast, cereal and cream soup are fed at an
interval of an hour
• Avoid highly seasoned and spicy foods
Management Cont’d
• The amount of food and the number of
feedings are increased according to the
patient’s tolerance until eating a full regular
diet
• Therapeutic diet: soft diet
Chronic Gastritis
Presence of chronic mucosal
inflammatory changes such as erosions,
ulcerations, changes in the blood vessels,
and the destruction of the surface cells
Same dietary indiscretions as acute
gastritis
Illness precedes development of organic
gastritis lesions
Chief manifestation is pain
Chronic Gastritis
Dietary Management
• Provide adequate calories & nutrients
• Start patient on soft diet
• Avoid highly seasoned foods
• Excess liquids during meals is avoided to
reduce discomfort
• Frequent small meals are recommended
• Anti-acid therapy
Therapeutic Diet: Soft diet
Peptic Ulcer Disease (PUD)
• One of the most common diseases affecting
the GIT
• It causes inflammatory injuries in the
gastric or duodenal mucosa with an
extension to submucosa and into mucularis
mucosa
• Acidic environment is believed to be the
principal cause of PUD
Pathophysiology
The normal stomach maintains a balance
between protective factors, such as mucus
secreted by the glands from the lower
esophagus to the upper duodenum and
sodium bicarbonate from the pancreas to
neutralize HCL for the protection from its
strong acidic environment
Pathophysiology
In alkaline environment, pepsin is inactivated
and cannot digest the duodenal mucosa
Gastric ulcers develop when aggressive
factors overcome protective mechanisms
Pathophysiology
• The two major etiological factors for PUD
are Helicobacter pylori infection and
nonsteroidal anti-inflammatory drug
(NSAID) consumption. Currently, 70% of
all gastric ulcers occurring in the United
States can be attributed to H pylori
infection.
• Sanjeeb Shrestha, MD, Consulting Staff, Division of Gastroenterology, North West Arkansas Gastroenterology Clinic
Daryl Lau, MD, MPH, FRCP(C), Director of Translational Liver Research, Beth Israel Deaconess Medical Center; Associate
Professor of Medicine, Harvard Medical School
• Updated: Aug 24, 2009
Pathophysiology
• Cigarette smoking can affect gastric
mucosal defense adversely. Cigarette
smoking is believed to play a facultative
role in H pylori infection. People who
smoke tend to develop more frequent and
recurrent ulcers and their ulcers are more
resistant to therapy
PUD
Most common portion of the GIT affected by
PUD:
First portion of the duodenum
The antrum of the stomach
The gastroesophageal junction
Ulcer is in the duodenum called duodenal
ulcer (DU)
Ulcer is found in the stomach called gastric
ulcer (GU)
H. Pylori
• A cytotoxin-associated gene (cag A) has
been isolated in approximately 65% of the
bacteria. The products of this gene are
associated with more severe gastritis,
gastric ulcer, gastric cancer, and
lymphoma.
H. Pylori
H pylori infection also predisposes patients
to ulcer disease by disrupting mucosal
integrity. The bacterium's spiral shape and
flagella facilitate its penetration into the
mucous layer and its attachment to the
epithelial layer. Subsequently, it releases
phospholipase and proteases, which cause
further mucosal damage.
Duodenal Ulcer
More common than gastric ulcer
Usually appear within 3 cm of the
pylorus an area where gastric acidity is
high
More prevalent in male than in female
Usually affect people who are tense,
hardworking, and chronic worriers
Duodenal Ulcer
Clinical feature: an intense burning epigastric
pain 90 minutes to 3 hours after a meal
Aggravated at night and is usually relieved by
food
Diagnosis of DU is done by endoscopy or
upper GI barium radiography
Increased acid load to the duodenum leads to
the development of DU
Gastric Ulcer
Majority of gastric ulcers are situated in the
antrum or the lesser curvature of the
stomach
H. pylori is the primary cause for GU
Gastric acid secretory rates with GU are
normal or even decreased
Gastritis and chronic use of salicylate or
NSAIDs are other possible causes of GU
Predisposing Factors
• poor dietary habits
• excessive smoking
• drinking of caffeine (coffee and sodas) and
alcohol
• Rush through meals
• irregular mealtimes
• Hereditary
• Physical and psychological stresses
Objectives
• Relief pain
• healing of the ulcer
• prevention of complications and
recurrences
• Suppression and eradication of H. pylori is
indicated for PUD
• done by the use of triple or quadruple drug
therapy
Medical Treatment
• antacids can be used to neutralize the
overload of acids (Tums, Maalox)
• Acid secretion may be subdued by the use of
anticholinergics like Histamine 2 receptor
blockers (cimetidine, ranitidine, and
famotidine) w/c block the H2 receptor in the
parietal cells
• Mucosal protectant: Bismuth or Sucralfate
can also be effective in healing gastric ulcer
Medical Treatment
• Proton Pump Inhibitors (PPI): irreversibly
inhibit the H/K ATPase pump effectively
inhibiting acid release (omeprazole,
lansoprazole, esomeprazole)
• H. Pylori eradication: triple therapy has
consistently been shown to eradicate the
organism more than 90% of the time.
Drug therapy
• Bismuth Subsalicylate (2 tablets QID), plus
Metronidazole (250 mg tablet QID) plus
tetracycline (500 mg tablet QID).
• omeprazole (20 mg tablet OD), bismuth
Subsalicylate (2 tablets QID),
Metronidazole (250 mg tablet QID) and
tetracycline (500 mg tablet QID)
Drug therapy
Bismuth, metronidazole, and tetracycline qid with
H2 blockers bid
Bismuth, metronidazole, and tetracycline bid with a
PPI (Helidac)
Prevacid, amoxicillin, and clarithromycin bid
(PrevPac)
Prilosec, metronidazole, and clarithromycin bid
Ranitidine, bismuth, and clarithromycin with
amoxicillin, metronidazole, or tetracycline bid